133 related articles for article (PubMed ID: 14659917)
61. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.
Mirandola L; Figueroa JA; Phan TT; Grizzi F; Kim M; Rahman RL; Jenkins MR; Cobos E; Jumper C; Alalawi R; Chiriva-Internati M
Oncotarget; 2015 Feb; 6(5):2812-26. PubMed ID: 25739119
[TBL] [Abstract][Full Text] [Related]
62. Perspectives of SEREX-defined antigens in diagnosis and immunotherapy for gastric cancer.
Wang Y; Gu Q; Liu B; Zhu Z
Cancer Biol Ther; 2004 Sep; 3(9):806-11. PubMed ID: 15467426
[TBL] [Abstract][Full Text] [Related]
63. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients.
Minenkova O; Pucci A; Pavoni E; De Tomassi A; Fortugno P; Gargano N; Cianfriglia M; Barca S; De Placido S; Martignetti A; Felici F; Cortese R; Monaci P
Int J Cancer; 2003 Sep; 106(4):534-544. PubMed ID: 12845649
[TBL] [Abstract][Full Text] [Related]
64. Antigen identification using SEREX.
Sahin U; Türeci O
Methods Mol Biol; 2013; 1061():59-77. PubMed ID: 23963930
[TBL] [Abstract][Full Text] [Related]
65. Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens.
Chen YT; Gure AO; Scanlan MJ
Methods Mol Med; 2005; 103():207-16. PubMed ID: 15542909
[TBL] [Abstract][Full Text] [Related]
66. Identification of specific autoantigens in Sjögren's syndrome by SEREX.
Uchida K; Akita Y; Matsuo K; Fujiwara S; Nakagawa A; Kazaoka Y; Hachiya H; Naganawa Y; Oh-Iwa I; Ohura K; Saga S; Kawai T; Matsumoto Y; Shimozato K; Kozaki K
Immunology; 2005 Sep; 116(1):53-63. PubMed ID: 16108817
[TBL] [Abstract][Full Text] [Related]
67. Tumor-associated antigenic pattern in squamous cell carcinomas of the head and neck--analysed by SEREX.
Heubeck B; Wendler O; Bumm K; Schäfer R; Müller-Vogt U; Häusler M; Meese E; Iro H; Steinhart H
Eur J Cancer; 2013 Mar; 49(4):e1-7. PubMed ID: 16837193
[TBL] [Abstract][Full Text] [Related]
68. Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer.
Heller A; Zörnig I; Müller T; Giorgadze K; Frei C; Giese T; Bergmann F; Schmidt J; Werner J; Buchler MW; Jaeger D; Giese NA
Cancer Immunol Immunother; 2010 Sep; 59(9):1389-400. PubMed ID: 20514540
[TBL] [Abstract][Full Text] [Related]
69. Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica.
Schmits R; Kubuschok B; Schuster S; Preuss KD; Pfreundschuh M
Clin Exp Immunol; 2002 Feb; 127(2):379-85. PubMed ID: 11876765
[TBL] [Abstract][Full Text] [Related]
70. Application of serex-analysis for identification of human colon cancer antigens.
Garifulin OM; Kykot VO; Gridina NY; Kiyamova RG; Gout IT; Filonenko VV
Exp Oncol; 2015 Sep; 37(3):173-80. PubMed ID: 26422100
[TBL] [Abstract][Full Text] [Related]
71. Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.
Alsøe L; Stacy JE; Fosså A; Funderud S; Brekke OH; Gaudernack G
J Immunol Methods; 2008 Jan; 330(1-2):12-23. PubMed ID: 18045611
[TBL] [Abstract][Full Text] [Related]
72. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
73. Rethinking Autoantibody Signature Panels for Cancer Diagnosis.
Campa MJ; Gottlin EB; Herndon JE; Patz EF
J Thorac Oncol; 2017 Jun; 12(6):1011-1014. PubMed ID: 28126538
[TBL] [Abstract][Full Text] [Related]
74. Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
Usener D; Gerhardt A; Schadendorf D; Eichmüller S
Br J Dermatol; 2003 Aug; 149(2):282-8. PubMed ID: 12932233
[TBL] [Abstract][Full Text] [Related]
75. A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.
Somers VA; Brandwijk RJ; Joosten B; Moerkerk PT; Arends JW; Menheere P; Pieterse WO; Claessen A; Scheper RJ; Hoogenboom HR; Hufton SE
J Immunol; 2002 Sep; 169(5):2772-80. PubMed ID: 12193752
[TBL] [Abstract][Full Text] [Related]
76. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
Scanlan MJ; Gout I; Gordon CM; Williamson B; Stockert E; Gure AO; Jäger D; Chen YT; Mackay A; O'Hare MJ; Old LJ
Cancer Immun; 2001 Mar; 1():4. PubMed ID: 12747765
[TBL] [Abstract][Full Text] [Related]
77. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
78. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.
Güre AO; Altorki NK; Stockert E; Scanlan MJ; Old LJ; Chen YT
Cancer Res; 1998 Mar; 58(5):1034-41. PubMed ID: 9500467
[TBL] [Abstract][Full Text] [Related]
79. Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour.
Hansen MH; Ostenstad B; Sioud M
Int J Oncol; 2001 Dec; 19(6):1303-9. PubMed ID: 11713604
[TBL] [Abstract][Full Text] [Related]
80. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
